-+ 0.00%
-+ 0.00%
-+ 0.00%

VIRIDIAN THERAPEUTICS - VRDN-008 DEMONSTRATES FAVORABLE SAFETY PROFILE IN PHASE 1 TRIAL

Reuters·11/09/2026 12:04:07